Cite
Table S2 from Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress–Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid Cancer
MLA
Robert F. Gagel, et al. Table S2 from Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress–Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid Cancer. Apr. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2bcc58c9f2e9d6fee836dacfedb35ab1&authtype=sso&custid=ns315887.
APA
Robert F. Gagel, Steven I. Sherman, Gilbert J. Cote, Yue Lu, Ling Li, Krishna M. Sinha, & Rozita Bagheri-Yarmand. (2023). Table S2 from Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress–Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid Cancer.
Chicago
Robert F. Gagel, Steven I. Sherman, Gilbert J. Cote, Yue Lu, Ling Li, Krishna M. Sinha, and Rozita Bagheri-Yarmand. 2023. “Table S2 from Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress–Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid Cancer,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2bcc58c9f2e9d6fee836dacfedb35ab1&authtype=sso&custid=ns315887.